Recent articles tagged with
Nevada bill would require insulin makers to post profits
Who wins and loses with the 21st Century Cures Act?
Column: Our zeal for antibiotics in agriculture could become an economic nightmare
News Wrap: Embattled pharma CEO takes Fifth before Congress
How drug companies are gaming an old law for greater profits
Is profit or innovation driving the rising costs of drugs?
After controversy, pharmaceutical company will lower price of AIDS drug
Powerful new class of cholesterol drugs offers hope for some patients
Drugmaker settles for $512 million in suit over delayed generics
The wealthiest are getting wealthier, and lobbying has a lot to do with it